anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Alkermes · conference-presentation

Alkermes | Results Presentation Deck | 31 slides

31 pages · 4 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

Alkermes | Results Presentation Deck | 31 slides

Alkermes · 2021-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 31 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Situation & Context 4 slides 100% 4/4 slides 100% 4/4 slides · 16 hits
— 0/4 slides
— 0/4 slides
— 0/4 slides
100% 4/4 slides
— 0/4 slides
Problem & Complication 4 slides 100% 4/4 slides 100% 4/4 slides · 14 hits
— 0/4 slides
— 0/4 slides
— 0/4 slides
100% 4/4 slides 100% 4/4 slides Evidence & Proof 13 slides 100% 13/13 slides 100% 13/13 slides · 58 hits
— 0/13 slides
30.8% 4/13 slides 7.7% 1/13 slides 100% 13/13 slides 100% 13/13 slides Impact & Next Steps 10 slides 100% 10/10 slides 100% 10/10 slides · 47 hits
— 0/10 slides
60% 6/10 slides · 9 hits 10% 1/10 slides 100% 10/10 slides
— 0/10 slides

Slide inventory

31
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Situation & Context
02
other
Open slide detailBeat · Situation & Context
03
introduce_nominees
Open slide detailBeat · Situation & Context
04
transition
Open slide detailBeat · Situation & Context
05
The slide uses a human body diagram to map clinical response areas.establish_context
Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction
06
RP2D: Recommended Phase 2 Dosesummarize
Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction
07
The slide uses a table-like structure to organize clinical trial programs by name, phase, and study details.plan_implementation
Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction
08
transition
Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction
09
The slide uses a process flow diagram to show how patients move from dose escalation (Part A) to expansion (Part B) and combination therapy (Part C).present_framework
Open slide detailBeat · Evidence & ProofLoop · Zoom In
10
Data as of March 19, 2021.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
11
Slide provides status update on clinical trial enrollment as of May 25, 2021.summarize
Open slide detailBeat · Evidence & ProofLoop · Zoom In
12
The chart is a swimmer plot, a common clinical trial visualization for patient-level response over time.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
13
Data cut off May 3, 2021.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
14
The chart is a swimmer plot, a common visualization in oncology clinical trials to show patient-level treatment duration and response.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
15
Data cut off May 3, 2021. PR = Partial Response.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
16
The slide details specific patient cohorts categorized by dosage and tumor type/treatment history.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
17
Data cut off May 3, 2021. Includes patient-level data for 7 patients.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
18
The chart displays individual patient responses categorized by tumor type. Stable disease is indicated by the shaded region between -30% and +20%.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
19
Data cut off May 3, 2021.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
20
The chart uses a waterfall plot format to visualize clinical trial efficacy data across multiple tumor types.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Zoom In
21
Includes clinical trial abbreviations at the bottom.summarize
Open slide detailBeat · Evidence & ProofLoop · Zoom In
22
transition
Open slide detailBeat · Impact & Next Steps
23
The slide outlines the transition from dose-finding cohorts to a specific expansion phase.plan_implementation
Open slide detailBeat · Impact & Next Steps
24
The slide uses a three-column layout to summarize clinical trial safety data.summarize
Open slide detailBeat · Impact & Next Steps
25
Data cut off March 19, 2021. Serum concentrations after the first dose of SC nemvaleukin.analyze_data
Open slide detailBeat · Impact & Next Steps
26
Includes both longitudinal line charts and bar charts for maximum fold change.analyze_data
Open slide detailBeat · Impact & Next Steps
27
Includes patient timeline, biomarker (CA-125) trend, target lesion size comparison, and CT scan imagery.illustrate_case
Open slide detailBeat · Impact & Next Steps
28
summarize
Open slide detailBeat · Impact & Next Steps
29
summarize
Open slide detailBeat · Impact & Next Steps
30
transition
Open slide detailBeat · Impact & Next Steps
31
state_next_steps
Open slide detailBeat · Impact & Next Steps